Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 09-2019 | |
| Operating Expenses | 0 | 13,100 |
| Operating Income | N/A | -13,100 |
| Interest Expense | 0 | 113 |
| Other Income | 0 | 121 |
| Pre-tax Income | 0 | -13,092 |
| Net Income Continuous | N/A | -13,092 |
| Net Income | $N/A | $-13,092 |
| EPS Basic Total Ops | N/A | -3.05 |
| EPS Basic Continuous Ops | N/A | -3.05 |
| EPS Diluted Total Ops | N/A | -3.05 |
| EPS Diluted Continuous Ops | N/A | -3.05 |
| EBITDA(a) | $N/A | $-13,100 |